HQH Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):

Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe...

Stats
Today's Volume	95 892.00
Average Volume	158 677
Market Cap	800.69M
Last Dividend	$0.590 ( 2024-05-22 )
Next Dividend	$0 ( N/A )
P/E	15.19
ATR14	$0.0120 (0.07%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-09	Goetz Kathleen	Buy	525	Common Stock
2024-03-13	Tse Loretta	Buy	0
2023-12-21	Goodson Alan R	Buy	170	Common stock
2024-01-02	Reit Todd	Buy	1 000	Common Stock
2023-12-28	Maher Bill	Buy	1 000	Common Stock

INSIDER POWER
100.00
Last 54 transactions
Buy: 113 661 \| Sell: 47 330

Volume Correlation

Long: 0.10 (neutral)

Short: 0.88 (strong)

Signal:(70.227) Same movement expected

Tekla Healthcare Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Tekla Healthcare Correlation - Currency/Commodity

-0.60
( weak negative )

-0.58
( weak negative )

0.00
( neutral )

-0.22
( neutral )

0.66
( moderate )

Tekla Healthcare Financials

Annual	2023
Revenue:	$58.12M
Gross Profit:	$47.22M (81.25 %)
EPS:	$1.140

FY	2023
Revenue:	$58.12M
Gross Profit:	$47.22M (81.25 %)
EPS:	$1.140

FY	2022
Revenue:	$-192.26M
Gross Profit:	$-203.56M (105.88 %)
EPS:	$-4.10

FY	2021
Revenue:	$157.10M
Gross Profit:	$0.00 (0.00 %)
EPS:	$3.49

Financial Reports:

No articles found.

Tekla Healthcare Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.400 (N/A)	$0.390 (N/A)	$0.420 (N/A)	$0.400 (N/A)	$0.400 (N/A)	$0.380 (N/A)	$0.480 (N/A)	$0.590 (N/A)	$0 (N/A)	$0 (N/A)

Tekla Healthcare Dividend Information - Dividend King

Dividend Sustainability Score: 3.57 - low (18.72%) | Divividend Growth Potential Score: 1.097 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0200	1987-12-21
Last Dividend	$0.590	2024-05-22
Next Dividend	$0	N/A
Payout Date	2024-06-28
Next Payout Date	N/A
# dividends	106	--
Total Paid Out	$57.41	--
Avg. Dividend % Per Year	7.66%	--
Score	6.27	--
Div. Sustainability Score	3.57
Div.Growth Potential Score	1.097
Div. Directional Score	2.33	--

Next Divdend (Est)
(2024-08-28)

$0.596 Estimate 70.14 %

Dividend Stability

0.94 Excellent

Dividend Score

6.27

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
1987	$0.0200	0.21%
1988	$0.00500	0.08%
1989	$0	0.00%
1990	$0	0.00%
1991	$0.960	8.82%
1992	$0	0.00%
1993	$0	0.00%
1994	$0	0.00%
1995	$1.220	9.04%
1996	$4.49	21.90%
1997	$1.070	6.29%
1998	$0.280	1.79%
1999	$1.330	8.94%
2000	$5.09	23.30%
2001	$3.48	14.60%
2002	$2.63	10.30%
2003	$1.680	11.60%
2004	$1.551	8.36%
2005	$1.590	8.65%
2006	$1.460	8.18%
2007	$1.460	8.89%
2008	$1.720	10.40%
2009	$0.520	4.38%
2010	$0.660	5.51%
2011	$1.260	9.39%
2012	$1.410	9.87%
2013	$1.730	9.74%
2014	$2.22	8.39%
2015	$3.55	11.10%
2016	$2.07	7.15%
2017	$1.980	9.13%
2018	$1.930	8.41%
2019	$1.720	9.35%
2020	$1.900	9.09%
2021	$2.04	8.76%
2022	$1.710	7.12%
2023	$1.600	8.82%
2024	$1.070	6.34%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend King	2023-06-30	Quarterly	2	5.23%	8.53
ACP	Dividend Royal	2024-05-22	Monthly	14	11.88%	8.50
PVL	Dividend Royal	2023-11-15	Monthly	14	9.37%	8.50
ARR	Dividend Royal	2024-05-14	Monthly	15	11.08%	8.50
ACV	Dividend Royal	2024-06-13	Monthly	10	10.19%	8.50
AVK	Dividend Royal	2024-05-14	Monthly	22	9.54%	8.31
AFG	Dividend Royal	2024-04-12	Bi-Monthly	39	9.39%	8.06
JPT	Dividend King	2023-11-02	Monthly	8	4.19%	8.05
VCIF	Dividend Royal	2023-08-18	Monthly	6	8.05%	8.02
EDI	Dividend Royal	2023-12-07	Monthly	13	8.85%	7.94

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.800	1.500	10.00	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0906	1.200	6.98	8.38	[0 - 0.3]
returnOnEquityTTM	0.0885	1.500	-0.128	-0.192	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	5.97	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	34.47	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	0.000186	1.500	-1.110	-1.665	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
freeCashFlowPerShareTTM	0	2.00	0	0	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.897	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.528	1.000	1.441	1.441	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0.113	0.800	-2.58	-2.06	[0.5 - 2]
Total Score				3.57

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	9.69	1.000	9.12	0	[1 - 100]
returnOnEquityTTM	0.0885	2.50	-0.0824	-0.192	[0.1 - 1.5]
freeCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
dividendYielPercentageTTM	11.17	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.0446	1.500	-3.63	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0	1.000	-2.50	0	[0.1 - 0.5]
Total Score				1.097

Tekla Healthcare Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Tekla Healthcare

Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.